期刊
GENE EXPRESSION
卷 16, 期 3, 页码 109-127出版社
COGNIZANT COMMUNICATION CORP
DOI: 10.3727/105221615X14181438356210
关键词
Platelet-derived growth factor (PDGF); Liver development; Liver regeneration; Hepatic fibrosis; Cirrhosis; Hepatocellular carcinoma; Cholangiocarcinoma; beta-Catenin; NF-kappa B;; Transforming growth factor-beta (TGF-beta); Oxidative stress; Sorafenib; IMC-3G3; APA5
资金
- NIH [R01DK095498]
- Endowed Chair for Experimental Pathology
- Angiogenesis Training Program [T32HL094295]
Platelet-derived growth factor receptor alpha (PDGFR alpha) is an isoform of the PDGFR family of tyrosine kinase receptors involved in cell proliferation, survival, differentiation, and growth. In this review, we highlight the role of PDGFR alpha and the current evidence of its expression and activities in liver development, regeneration, and pathology-including fibrosis, cirrhosis, and liver cancer. Studies elucidating PDGFR alpha signaling in processes ranging from profibrotic signaling, angiogenesis, and oxidative stress to epithelial-to-mesenchymal transition point toward PDGFR alpha as a potential therapeutic target in various hepatic pathologies, including hepatic fibrosis and liver cancer. Furthermore, PDGFR alpha localization and modulation during liver development and regeneration may lend insight into its potential roles in various pathologic states. We will also briefly discuss some of the current targeted treatments for PDGFR alpha, including multireceptor tyrosine kinase inhibitors and PDGFR alpha-specific inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据